The fight against severe migraines and cluster headaches sees first success with Salvia’s foil implant

A bioelectronic foil implant has given a 29-year-old woman from Australia immediate relief from her severe migraine symptoms. Her two sons are so grateful that they named their new fish Salvia – after the company that supplied the implant.

Highlights

• One in seven people suffer from migraines.
• Salvia implanted a foil in a migraine patient for the first time to relieve symptoms.
• The result provides confidence for the future of this technology.

For Salvia BioElectronics, based at the High Tech Campus in Eindhoven, the implantation was a big success in the fight against migraine and cluster headache attacks. Not before have these paper-thin bioelectronic films been used against severe headaches. “An extraordinary milestone, ushering in a new era of possibilities in medical care,” said CEO Hubert Martens.

Salvia BioElectronics was founded in 2017 by international experts in the field of neuromodulation. Since then, the team has been building an effective, safe, and accessible neuromodulation method to combat chronic migraine.

Migraines affect one in seven people, mostly women. More than five percent of people with migraines suffer from chronic migraines, with an average of 22 headache days per month. Despite currently approved medical methods, patients with chronic migraine find little relief.